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Perinatal Complications and Aging Indicators
by Midlife
WHAT’S KNOWN ON THIS SUBJECT: Perinatal complications
predict increased risk for morbidity and early mortality. Evidence
of perinatal programming of adult mortality raises the question
of what mechanisms embed this long-term effect. Telomere length
and perceived facial age are 2 indicators of accelerated aging.
WHAT THIS STUDY ADDS: Perinatal complications predicted
greater signs of accelerated aging “inside,” as measured
objectively by leukocyte telomere length, an indicator of cellular
aging, and “outside,” as measured subjectively by perceived age,
an indicator of declining integrity of tissues.
abstract
BACKGROUND: Perinatal complications predict increased risk for mor-
bidity and early mortality. Evidence of perinatal programming of adult
mortality raises the question of what mechanisms embed this long-term
effect. We tested a hypothesis related to the theory of developmental
origins of health and disease: that perinatal complications assessed at
birth predict indicators of accelerated aging by midlife.
METHODS: Perinatal complications, including both maternal and neo-
natal complications, were assessed in the Dunedin Multidisciplinary
Health and Development Study cohort (N = 1037), a 38-year, prospec-
tive longitudinal study of a representative birth cohort. Two aging
indicators were assessed at age 38 years, objectively by leukocyte
telomere length (TL) and subjectively by perceived facial age.
RESULTS: Perinatal complications predicted both leukocyte TL (b =20.101;
95% confidence interval, 20.169 to 20.033; P = .004) and perceived age
(b = 0.097; 95% confidence interval, 0.029 to 0.165; P = .005) by midlife. We
repeated analyses with controls for measures of family history and social
risk that could predispose to perinatal complications and accelerated
aging, and for measures of poor health taken in between birth and the
age-38 follow-up. These covariates attenuated, but did not fully explain the
associations observed between perinatal complications and aging
indicators.
CONCLUSIONS: Our findings provide support for early-life developmental
programming by linking newborns’ perinatal complications to accelerated
aging at midlife. We observed indications of accelerated aging “inside,” as
measured by leukocyte TL, an indicator of cellular aging, and “outside,” as
measured by perceived age, an indicator of declining tissue integrity. A
better understanding of mechanisms underlying perinatal programming
of adult aging is needed. Pediatrics 2014;134:e1315–e1323
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ARTICLE
Themodel of the developmental origins
of health and disease suggests that
impairedgrowthinuteromaypermanently
change the body’s function and metabo-
lism, resulting in accelerated aging.1 Ad-
verse conditionsduring early development
exert a major impact on the etiology and
programming of late-life chronic diseases
and early mortality.2–6 Evidence of perina-
tal programming of adult mortality raises
the question of what mechanisms embed
this long-term effect. We tested the hy-
pothesis that perinatal complications
are associated with biomarkers of ac-
celerated aging already atmidlife, before
onset of aging-related diseases.
Two biomarkers associated with accel-
erated aging are telomere length (TL)
and perceived age.7,8 Telomeres, the
protective caps at the end of chromo-
somes, erode in somatic tissues with
each division of a cell. Both animal and
human studies support a link between
short TL and early mortality.9–13 Thus,
the length of telomeres has been pro-
posed as a “biological clock” for study-
ing cellular aging across the life span
and can be observed already in midlife
while people are still healthy.14,15 New
work has raised the possibility of
fetal programming of telomere biol-
ogy, whereby stress-relatedmaternal–
placental–fetal interactions during
intrauterine growth regulate the initial
setting of TL at birth.6,16,17 Perceived
facial age is an assessment of how old
a person looks relative to his or her
chronological age. The visual signs of
aging (eg, skin wrinkles) reflect declining
tissue integrity, indicative of the aging
process.18 Perceived age is widely used
as a general indicator of health by clini-
cians and is correlated with both TL and
early mortality.8,18,19
We tested the hypothesis that people
whoexperiencedperinatalcomplications
would exhibit these signs of accelerated
aging by midlife. We followed a cohort
prospectively from birth to age 38 years
and tested whether those with perinatal
complications(assessedatbirth)exhibited
greater signs of aging inside and outside,
that is, at the cellular level (TL) and at the
level of facial appearance (perceived age).
METHODS
Participants
Participants aremembers of the Dunedin
Multidisciplinary Health and Development
Study, a longitudinal investigation of
health and behavior in a complete birth
cohort. Studymembers (N= 1037; 91.0%
of eligible births; 52.0% male) were all
born between April 1972 and March
1973 in Dunedin, New Zealand, were el-
igible for the longitudinal study based
on residence in the Otago province at
age 3, and participated in the first
follow-up assessment at age 3. The co-
hort represents the full range of socio-
economic status (SES) in the general
population of New Zealand’s South Island
and is primarily white. Assessments
were carried out at birth and at ages 3, 5,
7, 9, 11, 13, 15, 18, 21, 26, 32, and, most
recently, 38 years, when 95.4% of the
1007 living study members underwent
assessment in 2010 to 2012. At each as-
sessment wave, each study member is
brought to the Dunedin Research Unit for
a full day of interviews and examinations.
All analyses reported in this study were
restricted to white study members who
consented to phlebotomy and facial
photographs at the age-38 assessment
and had data on all measures used here
(N = 829). DNA for study members of
Maori ancestry is not transported to
Duke University for analysis for cultural
reasons. There have been 30 deaths
since age 3; however, these deaths were
not due to aging-related diseases. Causes
include road accidents, suicide, overdose,
and childhood cancers. By age 38 years, 8
of 829 study members had developed an
aging-related diagnosis of type II diabetes,
heart attack, stroke, or cancer. The Otago
Ethics Committee approved eachphase of
the study, and informed consent was
obtained from all study members.
Assessment of Perinatal
Complications
Each child was examined shortly after
birth, and perinatal information was
taken from the hospital records.20,21 As
previously described,20 the obstetric
complications assessed in this study,
including prenatal, intrapartum, and
neonatal complications, werematernal
diabetes, glycosuria, epilepsy, hyperten-
sion, eclampsia, antepartumhemorrhage,
accidental hemorrhage, placenta previa,
having had a previous small baby, ges-
tational age,37 weeks or.41 weeks,
birth weight,2.5 kg, small size for ges-
tational age, major or minor neurologic
signsof theneonatal period (eg, jitteriness,
tenseness, limpness, hypotonicity), Rh
incompatibility, ABO incompatibility, non-
hemolytic hyperbilirubinemia, hypoxia at
birth (idiopathic respiratory distress
syndrome or apnea), and low Apgar
score at birth. The infant was defined as
having a low Apgar score if 1 of the
following conditions applied: At 5
minutes of life, the infant’s heart rate
was 100 beats per minute, respiration
was irregular or absent, and the infant
was centrally cyanotic; the infant took
.10 minutes to establish normal res-
piration; or the infant’s asphyxia at birth
warranted resuscitation. The sum of
maternal complications and neonate
complications was significantly and
positively correlated (r = 0.156, P ,
.001). Based on evidence that the effects
of adverse conditions are cumulative,22,23
each conditionwasweighted equally and
summed to yield an obstetric complica-
tions index. A total of 530 studymembers
(63.9%) had 0 perinatal complications,
211 (25.5%) had 1 perinatal complication,
and 88 (11%) had$2.
Assessment of Aging Indicators
Measurement of Mean Relative TL at
Age 38 Years
We extracted leukocyte DNA from blood
using standard procedures.24,25 Age-38
DNA was stored at280°C until assayed,
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to prevent degradation of the samples.
All DNA samples were assayed for leuko-
cyte TL at the same time, independently of
caseness, and all operations were car-
ried out by a laboratory technician blind
to cases or controls. We measured TL by
using a validated quantitative polymerase
chain reaction method,26 as previously
described,27,28 which determinesmean TL
across all chromosomes for all cells
sampled. The method involves 2 quanti-
tative polymerase chain reactions for
each subject: 1 for a single-copy gene (S)
and the other in the telomeric repeat
region (T). All DNA samples were run in
triplicate for telomere and single-copy
reactions at age 38 years (ie, 6 reac-
tions per study member). The average
coefficient of variation for the triplicate
cycle threshold values was 0.82% for the
T and 0.48% for the S, indicating high as-
say precision. TL, asmeasuredby T/S ratio,
was normally distributed (Kolmogorov–
Smirnov tests of normality), with a skewof
0.48 and kurtosis of 0.38 at age 38.
Perceived Age at 38 Years
We took 2 measurements of perceived
age. First, “age range”was assessed by
an independent panel of 4 Duke Uni-
versity undergraduate raters. In a pre-
viousmethodology article it was shown
that raters’ gender, nationality, age,
and aging expertise had little effect on
the perceived age data generated.18
Raters were presented with standard-
ized (nonsmiling) facial photographs of
study members and were kept blind to
their actual age. Photoswere divided into
gender-segregated slideshow batches
containing ∼50 photos, viewed for 10
seconds each. Raters were randomly
assigned to viewing the slideshow
batches in either forward progression
or backward progression. They used
a Likert scale to categorize each study
member into a 5-year age range (ie,
from1=20–24 years old up to 10= 65–70
years; mean = 4.21, SD = 0.76). Scores for
each study member were averaged
across all raters (a = 0.71). The second
measure, “relative age”, was assessed
by a different panel of 4 Duke University
undergraduate raters. The raters were
told that all photos were of people aged
38 years old. Raters then used a 7-item
Likert scale to assign a relative age to
each study member (1 = young looking,
7 = old looking; mean = 4.14, SD = 0.91).
Scores for each study member were
averaged across all raters (a = 0.72).
“Age range” and “relative age” were
highly correlated (r = 0.73). To derive
a measure of perceived age at 38 years,
we standardized and averaged both
“age range” and “relative age” scores to
create perceived age at 38 years.
Alternative Explanatory Variables
Wetested formeasuresof familyhistory
and social risk that could predispose to
both perinatal complications and ac-
celerated aging, potentially creating an
artifactual association between them.
Furthermore,wetested formeasuresof
poor health taken between birth and
age-38 follow-up that are known out-
comesofperinatal complications,4,5,29–31
and couldmediate anassociationbetween
perinatal complications and accelerated
aging. These alternative explanatory vari-
ables have been previously published and
have good reliability and validity in this
cohort. They included family histories of
medical problems, childhood social ad-
versity, and poor cognitive health, mental
health, vascular health, or physical health.
All alternative explanatory variables are
described in Table 1.
Statistics
We tested the hypothesis that perinatal
complications predict aging indicators
at age 38 years by regressing each of
age-38 TL and age-38 perceived age on
a predictor variable indicating the
number of perinatal complications for
which study members met criteria. To
test the possibility that the association
between perinatal complications and
aging indicators was a consequence of
alternative explanatory variables, we
reanalyzed the association between peri-
natal complications and aging indicators,
controlling for these variables in ordinary
least squares multiple regression analy-
ses. We report standardized coefficients
and95%confidenceintervals(CIs)for the2
aging outcomes. Age was not controlled
statistically, because all study members
were the same age (1972–1973 births).
RESULTS
Both our subjective and objective aging
indicators were related in the expected
direction. Age-38 leukocyte TL and per-
ceived age were significantly and neg-
atively correlated (r =20.086, P = .01).
Study members with shorter telomeres
tended to look older.
Perinatal complications predicted both
age-38 TL (b =20.101; 95% CI,20.169
to20.033; P = .004) (Fig 1A) and age-38
perceived age (b = 0.097; 95% CI,
0.029–0.165; P = .005) (Fig 1B). Study
members who had more perinatal
complications had shorter telomeres
and looked older. Although women had
somewhat longer age-38 telomeres
than men (men = 1.038 T/S ratio;
women = 1.059 T/S ratio, P = .351),
associations between perinatal com-
plications and aging indicators did not
differ significantly between men and
women, which is consistent with
results of a recent meta-analysis.32
There was no significant interaction
between gender and perinatal compli-
cations predicting either TL (b =20.044;
95% CI,20.112 to 0.025; P = .21; the T/S
ratios for men with 0, 1, and$2 perinatal
complicationswere 1.075, 0.961, and 0.983;
the comparable T/S ratios for women
were 1.061, 1.103, and 0.955) or perceived
age (b = 0.010; 95% CI,20.059 to 0.078;
P = .78; the standardized perceived age
of men with 0, 1, and $2 perinatal
complications was 20.051, 0.118, and
0.209; the comparable scores for
womenwere20.132,20.055, and 0.131).
We next tested whether alternative
explanatory variables that may be
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TABLE 1 Description of Alternative Explanatory Variables That May Explain the Association Between Perinatal Complications and Aging Indicators at 38 y
Alternative Explanatory Variable Description Assessment Ages Perinatal Complications (Mean, SD)
Family histories of medical problems In 2003–2006, we interviewed study members and their
biological parents to obtain histories of medical problems
about study members’ first- and second-degree relatives.54
The following conditions were assessed: heart disease
(defined as a history of heart attack, balloon angioplasty,
coronary bypass, or angina), stroke, high blood pressure, high
cholesterol, diabetes, asthma, and cancer. We created the
family history score indicating medical problems by
calculating the proportion of a study member’s extended
family with a positive history of any medical problem.
Lifetime 0 (3.87, 1.13)
1 (3.72, 1.07)
$2 (3.66, 1.13)
Childhood social adversity The SES of study members’ families wasmeasured with a 6-point
scale assessing parents’occupational status. The scale places
each occupation into 1 of 6 categories (from 1, unskilled
laborer to 6, professional) on the basis of education levels and
income associated with that occupation in data from the New
Zealand census. Family SES was the average of the highest SES
level of either parent frombirth through age 15 y. This variable
reflects the socioeconomic conditions experienced by the
participants while they were growing up.
Birth to 11 y 0 (1.08, 0.50)
1 (1.12, 0.48)
$2 (1.15, 0.51)
Cognitive health Intelligence tests were administered in childhood at ages 7, 9, 11,
and 13 y and again in adulthood at age 38 y. We used the
Wechsler Intelligence Scale for Children–Revised55 and the
Wechsler Adult Intelligence Scale, Fourth Edition.56 These tests
comprise a series of subtests that yield indices standardized
to population norms (M = 100, SD = 15). To derive ameasure of
life course cognitive health, we created an average IQ score by
using data from 7 to 38 y.
7–38 y 0 (101.41, 13.73)
1 (99.49, 13.81)
$2 (96.57, 14.28)
Mental health Psychiatric disorders (according to theDiagnostic andStatistical
Manual of the American Psychiatric Association) were
assessed among study members via private structured
interviews using the Diagnostic Interview Schedule at ages 18,
21, 26, 32, and 38 y. We repeatedly assessed the following
disorders by using 1-year reporting periods: alcohol
dependence, cannabis dependence, dependence on hard
drugs, tobacco dependence (assessed with the Fagerstrom
Test for Nicotine Dependence),57 conduct disorder, major
depression, generalized anxiety disorder, fears and phobias,
obsessive–compulsive disorder, mania, and schizophrenia. As
previously described,58 we carried out confirmatory factor
analyses of these psychiatric disorders, taking into account
their persistence, co-occurrence, and sequential comorbidity,
from ages 18–38 y. The structure of mental disorders could be
summarized by 3 core psychopathological dimensions: an
internalizing liability to depression and anxiety, an
externalizing liability to antisocial and substance use
disorders, and a thought disorder liability to symptoms of
psychosis. At a higher-order level, we showed that these
liabilities themselves reflected 1 general underlying
dimension that summarized subjects’ propensity to develop
any form of common psychiatric and substance use
disorders.58 Higher scores on this dimension index persistent
and impairing mental illness.
18–38 y 0 (98.24, 13.93)
1 (101.14, 15.51)
$2 (99.14, 15.24)
Vascular health Bloodpressureat ages 26, 32, and 38 ywas assessed according to
standard protocols59 using a Hawksley random-zero
sphygmomanometer (Hawksley & Sons Ltd, Lancing, UK) with
a constant deflation valve. Systolic and diastolic blood
pressures were combined to derive a measure of mean
arterial pressure: [(2 3 diastolic) + systolic]/3. To derive
a measure of vascular health, we averaged all 3 mean arterial
pressure variables at 26, 32, and 38 y.
26–38 y 0 (89.41, 7.69)
1 (90.25, 7.63)
$2 (89.76, 7.25)
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associatedwithperinatalcomplications,
TL, and perceived age accounted for the
association between perinatal compli-
cations and aging indicators. Table 2
shows that shorter age-38 TL was sig-
nificantly correlated with family histo-
ries of medical problems and poor
cognitive health, mental health, and
vascular health (P , .05), but not with
childhood social adversity (low SES),
which is consistent with previous re-
search.33 Age-38 perceived age was
significantly correlated with childhood
social adversity and poor cognitive
health, mental health, and physical
health (P , .05). Controlling for these
alternative explanatory variables at-
tenuated, but did not fully explain the
associations observed between perina-
tal complications and aging indicators
(Table 2).
Finally, we tested whether specific peri-
natal complications were associated
with accelerated aging indicators. Al-
though our sample size was not large
enough to interrogate each specific type
of complication, we had enough cases to
interrogate the 2 most common compli-
cations: lowbirthweight (,2.5kg;N=43)
and small size for gestational age (N =
72).1,34,35 These 2 complications are not
synonymous; they were correlated at
r = 0.33, and only 29% of infants small
for gestational age were low birth
weight, as in the general population.
Low birth weight predicted both age-
38 TL (b = 20.074; 95% CI, 20.142
to 20.006; P = .03) and age-38 per-
ceived age (b = 0.092; 95% CI, 0.024 to
0.160; P = .008). Likewise, small size for
gestational age predicted both aging
indicators at 38 years (TL, b =20.074;
95% CI, 20.142 to 20.006; P = .03;
perceived age, b = 0.087; 95% CI, 0.019
to 0.155; P = .01).
TABLE 1 Continued
Alternative Explanatory Variable Description Assessment Ages Perinatal Complications (Mean, SD)
Physical health Physical health at ages 26, 32, and 38 y was measured by clinical
indicators of poor adult health, including metabolic
abnormalities (waist circumference, high-density lipoprotein
level, triglyceride level, blood pressure, and glycated
hemoglobin), poor cardiorespiratory fitness, poor pulmonary
function, periodontal disease, and systemic inflammation
(high-sensitivity C-reactive protein) (Supplemental Table 3).
Pregnant women were excluded from the reported analyses.
We summed the number of clinical indicators on which study
members exceeded clinical cutoffs at each age. To derive
a measure of physical health, we averaged all 3 physical
health indexes at 26, 32, and 38 y. (Blood pressure duplicates
vascular health, but we retained it in the physical health index
because it is a standard constituent of a clinical physical
health examination).




Associationbetweenperinatal complications and (A) leukocyte TL (T/S ratio) and (B)perceived facial age
(Z score) at midlife. Error bars reflect SEs.
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DISCUSSION
Followinga cohort frombirth tomidlife,
we found that newbornswhopresented
with more perinatal complications
exhibited greater signs of accelerated
aging at age 38 years. We observed
indications of accelerated aging inside,
as measured objectively by leukocyte
TL, an indicator of cellular aging, and
outside, as measured subjectively by
perceived age, an indicator of declining
tissue integrity.
This prospective longitudinal investiga-
tion has several strengths. First, all co-
hort members were the same age,
strengthening the test of variation in
their pace of aging. Second, the cohort
was young enough to detect variation
in aging indicators before diseases of
aging have begun to develop. Third,
we tested 2 indicators of accelerated
aging.Althoughsomecommentatorshave
questionedwhetherTL is anappropriate
biomarker of aging,36 we confirmed a
previous report that shorter TL is as-
sociated with older perceived age in
the expected direction.8
We used a perinatal complication index
that was previously shown to predict
cognitive problems in the Dunedin
Studyat ages3, 5, 7, 11, and13years.20,37
Notably, our index also predicted a
measure of cognitive health averaged
from 7 to 38 years (Table 2). There are
several approaches for scoring peri-
natal complications. The 3 most com-
mon are a present or absent count of
complications38,39 (as is our index),
a weighted severity scale based on a
clinician’s judgment of risk,40 and a
method that uses empirical probabili-
ties of morbidity associated with each
perinatal condition.41 A recent review
of these approaches for constructing
perinatal risk scales concluded that all
of them predict cognitive outcomes
similarly.23 This review also noted that
the ideal system should include prenatal,
intrapartum, and neonatal complications;
contain items that are commonly mea-
sured to assess perinatal risk; have a few
items rather than potentially hundreds;
and be able to predict developmental
outcomes in infancy and early childhood.
The Dunedin Study index fulfills these
requirements. Although some individual
complications can have strong predictive
utility,23 our sample size was not large
enough to interrogate each specific
complication individually (eg, Apgar score
or hypoxia). However, the 2most common
complications, lowbirthweight and small
size for gestational age, were significantly
associated with both aging indicators at
similar effect sizes.
We acknowledge limitations. First, the
Dunedin cohort is primarily white and
represents a single birth cohort born in
the 1970s. Replication of associations
between perinatal complications and
aging indicators in other ethnic groups
and cohorts is needed. Second, we did
not measure TL at birth, given that this
technology was not available in the
early 1970s, and perceived facial age is
not an appropriate measure in this
stage of development. This means that
we could study only individual differ-
ences in indicatorsof acceleratedaging
rather than changes from a neonate
baseline. Furthermore, we did not con-
trol for paternal age at conception, nor
did we measure TL in parents, and
therefore we could not interrogate
whether shorter TL in parents increased
neonates’ probability to develop com-
plications at birth. Facial age ratings
might be affected by factors apart from
aging (eg, sun exposure, fair complex-
ion), so thismeasure is somewhat noisy,
yet there is no obvious reason to sug-
gest such factors covary with perinatal
complications to confound our analy-
ses. Perinatal complications predicted
TL and facial aging at small effect sizes,
but they were comparable to the effect
size between perinatal complications
and cognitive health (IQ).
TABLE 2 Pearson Correlations and Multivariate Linear Regression Analyses of Perinatal Complications, Predicting Leukocyte TL and Perceived Age at
38 y, Controlling for Alternative Explanatory Variables and Gender (N = 829)
Bivariate Pearson Correlation Association Between Perinatal
Complications and TL at 38 y
Association Between Perinatal
Complications and Perceived
Age at Age 38
Perinatal
Complications
TL at 38 y Perceived
Age at 38 y
b (95% CI) P b (95% CI) P
Perinatal complications — — — 20.101 (20.169 to 20.033) .004 0.097 (0.029 to 0.165) .005
Controlling for alternative explanatory variables (and gender)
Family histories of medical problems 0.051 20.090** 0.007 20.097 (20.164 to 20.029) .005 0.096 (0.028 to 0.164) .006
Childhood social adversitya 20.070* 0.041 20.194** 20.098 (20.167 to 20.030) .005 0.083 (0.016 to 0.150) .01
Life course health
Cognitive healtha 20.111** 0.087* 20.186** 20.092 (20.161 to 20.024) .008 0.077 (0.010 to 0.144) .02
Mental health 0.055 20.070* 0.162** 20.097 (20.165 to 20.029) .005 0.088 (0.021 to 0.155) .01
Vascular health 0.033 20.069* 20.022 20.098 (20.166 to 20.029) .005 0.100 (0.031 to 0.168) .004
Physical health 0.031 20.057 0.193** 20.099 (20.167 to 20.031) .004 0.089 (0.022 to 0.156) .009
All variables — — — 20.084 (20.152 to 20.016) .02 0.075 (0.009 to 0.140) .02
a Higher scores indicate lower childhood social adversity or better cognitive health.
* P , .05;
** P , .01.
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Surprisingly, the association between
perinatal complications and aging indi-
cators was not explained by potentially
confounding measures of family history
and social risk that could predispose to
both perinatal complications and accel-
erated aging, nor was it explained by
potentiallymediatingmeasures of health
takenbetweenbirthandage-38follow-up.
This finding, though unexpected, is con-
sistent with previous reports that peri-
natal complications predict accelerated
aging independently of risk factors such
as childhood SES, adulthood SES, smok-
ing, and hypertension.42,43 If the associ-
ation between perinatal complications
and the rate of aging at midlife is truly
independent of family history and social
risks present before birth, and of health
states during the first half of the life
course, it would suggest that perinatal
complications are a primary exposure
rather than an indicator of some preex-
isting risk and that the aging indicators
we studied capture information not ob-
servable in outward manifestations of
health during the first half of the life
course.
Efforts to elaborate the model of the
developmental origins of health and
disease are concerned with potential
mechanisms of perinatal programming.
Our correlational observations suggest
the hypothesis of a cellular mechanism
linking perinatal complications with ac-
celerated aging through erosion of TL.44
Additional support for the accelerated
aging process is given by the observa-
tion that subjects with perinatal com-
plications tended to look older by
midlife. If replicated, the link between
perinatal complications and shorter TL
suggests several hypotheses for exper-
imental investigations. Future research
should elucidate the molecular path-
ways by which the connection between
perinatal complications and acceler-
ated aging occurs.4,14,45 Additional re-
search on younger people needs to test
when in life the effect of perinatal
complications on TL can initially be ob-
served. Moreover, clinical trials in NICUs
could incorporate TL or telomerase
measurements at birth, and thereafter
at follow-up, as a first step to test the
potential early reversibility of this de-
velopmental programming of disease.
Finally, there is interest in factors that
protect some people from the aging-
accelerating consequences of perinatal
complications. A challenge in pursuing
research on this topic is that it is difficult
to determine who is resilient until late in
life, when diseases of old age have had
time to develop. Facial aging and TL
provide an opportunity to identify adults




greater signs of accelerated aging by
midlife. Since our cohort was born
in the 1970s, advances in obstetric
medicine, particularly in developed
countries, have reduced infant mor-
tality and saved lives.46,47 Advances in
obstetric medicine in developing
regions, home to.80% of the world’s
population, will soon also increase the
number of survivors with perinatal
complications.48–50 Birth outcomes are
important determinants of a range of
adult attainments,47 and previous re-
search indicates that many newborns
who survive perinatal complications
carry a lifelong vulnerability to poor
health.2–5 Here we present evidence of
such sustained vulnerability emerg-
ing already in midlife, before aging-
related diseases begin to develop.
Understanding the underlying mech-
anism is critical to devising effective
intervention strategies. Our findings
encourage additional investigation of
the link between perinatal complica-
tions and indicators of aging in early
life.51–53
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